WASHINGTON, D.C. – House Ways and Means Committee Chairman Kevin Brady (R-TX), House Energy and Commerce Committee Chairman Greg Walden (R-OR),  and Senate Finance Committee Chairman Orrin Hatch (R-UT) issued the following statement regarding the Trump Administration’s decision to withdraw the Center for Medicare & Medicaid Innovation’s (CMMI) proposal to dramatically change how Medicare pays for Part B drugs:

“Today’s announcement is welcome news for seniors, ensuring the Obama Administration’s experiment that would have limited the critical care they and other Medicare beneficiaries need, will not be resurrected in the future. We are pleased the previous Administration did not proceed with their plan, and we commend the Trump Administration for going a step further and wiping the flawed proposal from the books for good. It’s also a win for health care providers, ensuring their work to serve vulnerable patients is not disrupted. We look forward to continuing our work to ensure CMMI and Medicare are working to meet the needs of the patients they serve.”